Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioTrove

BioTrove?uq=PEM9b6PF
1997 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer and manufacturer of innovative systems consisting of laboratory instruments and related consumables for genomic analysis, high-throughput screening and molecular diagnostics. The company's system consists of instruments and consumables for rapidly performing multiple simultaneous, yet independent, polymerase chain reactions (PCR) based genomic analysis on single or multiple samples, offering customers with an accelerated research process, and development and commercial progress across multiple fields, from drug discovery to agricultural science.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Acquirer
Primary Office
  • 12 Gill Street
  • Suite 4000
  • Woburn, MA 01801
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioTrove’s full profile, request a free trial.

BioTrove Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 15-Dec-2009 000.00 Completed Generating Revenue
12. Later Stage VC (Series C1) 25-Feb-2009 000.00 000.00 00000 Completed Generating Revenue
11. IPO 18-Dec-2008 0000 Cancelled Generating Revenue
10. Later Stage VC 04-Sep-2008 000.00 0000 Completed Generating Revenue
9. Later Stage VC 29-Aug-2007 00.00 000.00 Completed Generating Revenue
8. Later Stage VC (Series B1) 28-Feb-2006 000 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 14-Jul-2005 000 000.00 Completed Generating Revenue
6. Debt - General 08-Jun-2005 000 000.00 Completed Product Development
5. Accelerator/Incubator 01-Jan-2005 $19.1M Completed Product Development
4. Debt - General 02-Dec-2004 $75K $19.1M Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

BioTrove Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C1 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C 00,000,000 00.000000 00 00 00.0 00 00 00.000
Series B1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 45,802 $0.010000
Series A 250,000 $0.010000
To view this company’s complete Cap Table, request access »

BioTrove Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accretive Capital Partners Asset Manager Minority 000 0000 000000 0
BioFrontier Partners Venture Capital Minority 000 0000 000000 0
CB Health Ventures Venture Capital Minority 000 0000 000000 0
Catalyst Health Ventures Venture Capital Minority 000 0000 000000 0
Echelon Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »